Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02588027 · ClinicalTrials.gov registry record · NA

Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes

A NA study of Rotator Cuff Tear Arthropathy, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT02588027 is a NA study of Rotator Cuff Tear Arthropathy that has completed, run by University of California, San Francisco. The registered enrollment target is 110 participants, below the 3,444-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02588027, a NA study of Rotator Cuff Tear Arthropathy, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

This will be a randomized controlled trial to determine if postoperative ibuprofen after arthroscopic rotator cuff repair impacts postoperative opiate medication use, Visual Analog Scale (VAS) pain scores, shoulder range of motion (ROM), and repair integrity.

Interventions

  • DRUG Placebo
  • DRUG Ibuprofen

Study Locations (1)

California

  • UCSF Orthopaedic Institute - San Francisco

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2015-10
Est. Completion 2022-09
Phase NA

What the Registry Record Tells You About NCT02588027

The ClinicalTrials.gov registry entry for NCT02588027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,444-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tear Arthropathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02588027 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02588027 about?

NCT02588027 is a clinical study titled "Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes". This will be a randomized controlled trial to determine if postoperative ibuprofen after arthroscopic rotator cuff repair impacts postoperative opiate medication use, Visual Analog Scale (VAS) pain scores, shoulder range of motion (ROM), and repair integrity.

What is the current status of trial NCT02588027?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-10. Estimated completion is 2022-09.

What conditions does trial NCT02588027 study?

This clinical trial studies the following conditions: Rotator Cuff Tear Arthropathy.

What interventions are being tested in trial NCT02588027?

The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT02588027?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02588027 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tear Arthropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.